%) and IPD (10%). This promising growth was due to more subspecialties, more Operation : Consolidated Profit & Loss Statement 2Q 2Q % 6 mth 6 mth % Unit : THB million 2019 2018 change 2019 2018 change
Shareholder’s equity 108,363 127,110 143,956 Revenue 367,889 339,343 340,774 Expenses 346,990 314,569 313,740 Net Profit (Loss) 20,899 24,774 27,034 7. Expected Benefits The acquisition will provide a unique
to 0.35 Million Baht. However, in Q2 2018, the Company has loss on short term investment amounting of 0.37 Million Baht and decreased in LPG depot rental of 0.33 Million Baht. While in Q2 2018 training
order for the Company to grow in a sustainable manner in accordance with sufficiency economy philosophy. Important numbers in the financial statement Q2/2018 and 2017 Table 1: Profit/Loss Statement in Q2
. In addition, the new winning projects had decreased. Investments in joint ventures decreased by 17.6 MB or decrease of 17.2%, due to the recognition of share of loss from joint venture ‘s performance
activities of THB 314.5mn. The key components were the net loss of this 6 months period and cash paid for deposit of land. Net cash used in investing activities was THB 2,000.8mn. The key components were THB
recorded income incurred from deferred tax for the amount of THB 28.6 million. The net amount after amortization was 27.6 million in the first 6-month period of 2017 Operation : Consolidated Profit & Loss
in prepaid maintenance expenses, which those had decreased with the period of service. Investments in joint ventures decreased by 25.4 MB or decrease of 24.8%, due to the recognition of share of loss
. Also, the beginning cash has decreased and so did the ending cash. Important numbers in the financial statement Q3/2018 and 2017 Table 1: Profit/Loss Statement in Q3/2018 and 2017 Numbers Consolidated
change of scoring criteria effective this year despite an increase of average number of registered patients to 176,554 from 164,812 person yoy. Operation : Consolidated Profit & Loss Statement 3Q 3Q % 9